Skip to main content

Advertisement

Table 5 Outcomes at baseline and 1 year follow-up

From: Cost-effectiveness of adherence therapy versus health education for people with schizophrenia: randomised controlled trial in four European countries

  Adherence therapy (n = 204) Health education (n = 205) Adherence therapy – Health education1
Valid n Mean (SD) Valid n Mean (SD) Unadjusted comparisons Baseline-adjusted comparisons
Mean difference 95% confidence interval Mean difference 95% confidence interval
SF-36 MCS
Baseline 191 38.39 (11.22) 195 40.11 (12.15) -1.72 -4.14, 0.54 na na
1 year follow-up 175 40.24 (11.97) 192 41.32 (11.49) -1.08 -3.43, 1.42 -0.33 -2.41, 1.79
SF-36 utilities and QALYs
Baseline utility 191 0.66 (0.12) 192 0.68 (0.13) -0.02 -0.04, 0.01 na na
1 year follow-up utility 177 0.68 (0.14) 190 0.69 (0.13) -0.01 -0.04, 0.02 -0.005 -0.03, 0.02
1 year QALY gain 166 0.67 (0.11) 179 0.68 (0.12) -0.01 -0.04, 0.01 -0.002 -0.01, 0.01
EQ5D utilities and QALYs
Baseline utility 196 0.67 (0.30) 198 0.69 (0.28) -0.02 -0.08, 0.03 na na
1 year follow-up utility 174 0.68 (0.31) 193 0.74 (0.26) -0.06 -0.12, -0.003 -0.04 -0.09, 0.01
1 year QALY gain 170 0.67 (0.26) 188 0.72 (0.23) -0.05 -0.10, 0.01 -0.02 -0.05, 0.01
  1. 1. Based on bootstrapped linear regression of group upon cost (1000 repetitions).
  2. na = not applicable to baseline comparisons.